ArticleJournal of clinical immunology2024

Tolerability and Safety of Large-Volume Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% Administered with or without Dose Ramp-Up: A Phase 1 Study in Healthy Participants.

Zhaoyang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.